NMS and genetic drug oxidation
Open Access
- 1 October 1991
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 159 (4) , 595-596
- https://doi.org/10.1192/bjp.159.4.595
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland ChineseClinical Pharmacology & Therapeutics, 1989
- Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in luman beingsClinical Pharmacology & Therapeutics, 1989
- Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotypeClinical Pharmacology & Therapeutics, 1989
- Clinical implications of determination of plasma haloperidol levelsActa Psychiatrica Scandinavica, 1989
- Substantial rise in sparteine metabolic ratio during haloperidol treatment.British Journal of Clinical Pharmacology, 1989